Processing .....please wait.. 
The article has been forwarded.... 
Indian pharma market registers 12.9% growth
By agencies
|
Monday, 14 August 2006, 19:30 IST
NEW DELHI: The Indian pharmaceutical market has recorded a 12.9 percent growth in spite of fierce competition between major companies to capture shares.
The recent ORG-IMSS study reveals that Ranbaxy Laboratories along with Cipla led the growth market, registering growth rates of 13.7 percent and 16.6 percent respectively.
The other companies in the top five bracket were Zydus Cadilla, Nicholas Piramal and Glaxosmithkline (GSK), with 1.4 percent, 9 percent and 10.3 percent growth rates respectively.
In terms of market share, Ranbaxy with 5.13 percent holding has emerged the top company in June. GSK remains the close competitor with 5.12 percent.
However, in terms of the number of brands in the top 300 list, GSK has 24 products, whereas Ranbaxy has 19 followed by Cipla with 18 products making the grade.